Company / Operating Margin
Arcturus Therapeutics Holdings Inc. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-93.0%
FY2025
5-year range
-1641.3% / -46.9%
FY2021-FY2025
Trend
-48.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -46.9% to -93.0% over the past 2 years.
Based on SEC 10-K filings.
-93.0% in FY2025 with a 5-year CAGR of +45.5%.
Declined from -46.9% to -93.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +1548.4pp
- 5-Year Change
- +45.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 48.0% year-over-year.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -93.0% | -48.0% |
| FY2024 | -62.8% | -34.0% |
| FY2023 | -46.9% | +97.1% |
| FY2022 | -1641.3% | +0.0% |
| FY2021 | -1641.3% | -1085.4% |
| FY2020 | -138.5% | +0.0% |
| FY2019 | -138.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026